Skip to content
OpenCapital
Get started

Biofrontera Inc. BFRI Q3 2025 earnings

Reported November 12, 2025 · After market close

Revenue$7.0MMiss by $9.2MDiluted EPS-$0.59Beat by $0.01
Revenue estimate$16.1M
EPS estimate-$0.60

Next report

Aug 12, 2026 (in a month)
Revenue estimate$9.5M
EPS estimate-$0.11

Versus estimates

Revenue

Q1 2026$10.1MMiss by $166.0KQ4 2025$17.1MBeat by $950.0K
Q3 2025$7.0MMiss by $9.2M
Q2 2025$9.0MMiss by $520.0KQ1 2025$8.6MMiss by $2.0MQ4 2024$12.6MBeat by $2.1M

Diluted EPS

Q1 2026-$0.41Miss by $0.23Q4 2025$0.50Beat by $0.21
Q3 2025-$0.59Beat by $0.01
Q2 2025-$0.57Miss by $0.12Q1 2025-$0.47Miss by $0.33Q4 2024-$2.33Miss by $2.35

Ask the moment Biofrontera Inc. reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

When did Biofrontera Inc. report Q3 2025 earnings?
Biofrontera Inc. (BFRI) reported Q3 2025 earnings on November 12, 2025 after market close.
What were Biofrontera Inc.'s Q3 2025 revenue and EPS?
Biofrontera Inc. reported revenue of $7.0M and diluted EPS of $-0.59 for Q3 2025.
Did Biofrontera Inc. beat estimates in Q3 2025?
Revenue missed the consensus estimate of $16.1M by $9.2M. EPS beat the consensus estimate of $-0.60 by $0.01.
How did Biofrontera Inc.'s Q3 2025 results compare year-over-year?
Compared to the same quarter a year prior, revenue declined 22.5% from $9.0M a year earlier and diluted EPS grew 31.4% from $-0.86.
Where can I find Biofrontera Inc.'s Q3 2025 SEC filings?
You can read the 8-K earnings release (0001493152-25-021525) and the 10-Q periodic report (0001493152-25-021945) directly on SEC EDGAR. The filing index links above go to sec.gov.